Interpretation Bias Modification for Body Dysmorphic Disorder



Status:Completed
Conditions:Psychiatric
Therapuetic Areas:Psychiatry / Psychology
Healthy:No
Age Range:18 - 65
Updated:9/13/2018
Start Date:September 2015
End Date:March 2018

Use our guide to learn which trials are right for you!

Evaluation of an Internet-Based Treatment for Body Dysmorphic Disorder

The purpose of this study is to determine whether a computerized intervention designed to
reduce appearance and evaluation related interpretation biases will reduce symptoms
associated with body dysmorphic disorder.

The present study aims to examine the feasibility of a remote treatment for body dysmorphic
disorder delivered via the Internet. To evaluate the efficacy of the IBM protocol we have
developed in reducing negative appearance and evaluative related interpretations, we will
conduct a two-arm randomized controlled trial over the internet. Individuals with a diagnosis
of body dysmorphic disorder (N = 40) will be randomized to one of two conditions: 1) IBM or
2) progressive muscle relaxation. Each condition will consist of eight 10-25 minute treatment
sessions. Participants will complete two sessions per week for four weeks and will be
administered assessments at pre-treatment, one week post-treatment and at 3-month follow-up.
We hypothesize that: 1) IBM will lead to greater reductions in BDD symptoms than the PMR
condition; 2) IBM will lead to greater reductions in depression, anxiety and suicidal
ideation than the PMR condition; 3) IBM will lead to greater reductions in threat
interpretations and greater increases in benign interpretations than the PMR condition; 4)
The effects of condition on BDD symptoms will be mediated by changes in BDD-related
interpretation bias; and 5) The effects of training in the IBM condition will be maintained
at the 3-month follow-up assessments.

Inclusion Criteria:

- Current diagnosis of Body Dysmorphic Disorder according to DSM-5 criteria

- BDD-YBOCS score greater than or equal to 20

- Fluent in English

- No significant physical defect or flaw in appearance (e.g., disfiguration)

Exclusion Criteria:

- History of psychotic disorder, bipolar disorder, borderline personality disorder

- Current substance use disorder

- Unstable medication status (i.e. change in medication within the last month)

- Concurrent psychotherapy for appearance concerns

- Active and clinically significant suicidality
We found this trial at
1
site
Tallahassee, Florida 32304
Principal Investigator: Natalie L Matheny, BA
Phone: 571-758-3389
?
mi
from
Tallahassee, FL
Click here to add this to my saved trials